Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis

Objectives The coronavirus disease 2019 (COVID-19) pandemic has prompted many initiatives to identify safe and efficacious treatments, yet little is known regarding where early efforts have focused. We aimed to characterise registered clinical trials assessing drugs or plasma treatments […]

Click here to view original web page at Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis